The report of Neurostimulation Devices Market by Market Research Future comprises
extensive primary research along with the detail analysis of qualitative as well as
quantitative aspects by various industry experts and key opinion leaders to gain a deeper
insight of the market and industry performance. Neurostimulation is a modulation of the
nervous system’s activity. It is deliberately carried out by using invasive and non-invasive
techniques. Implantable stimulation devices are most commonly used in the treatment of
the neurological conditions such as epilepsy, Parkinson’s disease, dystonia, tremors,
depression, obsessive compulsive disorder, diabetic neuropathy and few other conditions.
Increasing cases of the neurological disorders such as chronic pain and depression high
adoption of the Neurostimulation therapy are likely to improve the Neurostimulation devices
Market. Globally, this market is growing steadily and it is anticipated to show an exponential
growth reaching approximately $11.5 billion in 2022
Neurostimulation Devices Market Segments:
Neurostimulation Devices Market has been segmented on the basis of type which comprises
implantable devices, and external devices. Implantable devices include deep brain
stimulators, spinal cord stimulators, sacral nerve stimulators, gastric electric stimulators,
cochlear implants, and vagus nerve stimulators; whereas external devices include
transcutaneous electrical nerve stimulator, and transcranial magnetic stimulator. On the
basis of application, the market is segmented into dystonia, epilepsy, Parkinson's disease,
depression, gastroparesis, pain management, tremors, urinary and fecal incontinence, and
others. On the basis of end user, market is segmented into hospitals/clinics, cognitive care
centers, research institutes and others.
Key Players for Neurostimulation devices Market: Autonomic Technologies, Boston
Scientific, ElectroCore, ImThera Medical, Inspire Medical Systems, LivaNova (Cyberonics),
Medtronic, NeuroMetrix, NeuroPace, Neuros Medical, NeuroSigma, Nevro Corporation, SPR
Therapeutics, St.Jude Medical, Synapse Biomedical, and others.
Access Sample Copy at https://www.marketresearchfuture.com/sample_request/2263 .
Regional Analysis of Neurostimulation devices Market:
Considering the global scenario of the market, Americas region is believed to be the largest
market for Neurostimulation devices. Moreover, the European market is also growing
continuously and slowly catching up with the American market. On the other hand, Asia-
Pacific market is expected to grow at the fastest pace in the Neurostimulation devices
segment during the forecast period. Middle East & Africa region are likely to have a limited
but steady growth in the market.
Table Of Contents
1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Neurostimulation Devices Market, By Type
6 Global Neurostimulation Devices Market, By Application
7 Global Neurostimulation Devices Market, By End User
8 Global Neurostimulation Devices Market, By Region
9 Competitive Landscape